The addition of ubiquitin to a substrate protein is called ubiquitination or ubiquitylation. Ubiquitination can affect proteins in many ways: it can signal for their degradation via the proteasome, alter their cellular location, affect their activity, and promote or prevent protein interactions. Ubiquitination is carried out in three main steps: activation, conjugation, and ligation, performed by ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s), respectively. The result of this sequential cascade binds ubiquitin to lysine residues on the protein substrate via an isopeptide bond, cysteine residues through a thioester bond, serine and threonine residues through an ester bond, or the amino group of the protein's N-terminus via a peptide bond.
Anti-Ubiquitin -http://www.stjohnslabs.com/ubiquitin-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress. Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3'. Activity suppressed by insulin. Main regulator of redox balance and osteoblast numbers and controls bone mass. Orchestrates the endocrine function of the skeleton in regulating glucose metabolism. Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity. Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP. In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC and PCK1. Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and SKT4/MST1. Promotes neural cell death. Mediates insulin action on adipose tissue. Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake. Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells. Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent
Anti-FoxO1-http://www.stjohnslabs.com/foxo1-antibody-p-92348
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Transferrin Antibody...St John's Laboratory Ltd
Transferrins are iron binding transport proteins which can bind two Fe3+ ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation.
Anti-Transferrin-http://www.stjohnslabs.com/transferrin-antibody-p-98689
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Acts as a calcium sensor for mitochondrial flash (mitoflash) activation, an event characterized by stochastic bursts of superoxide production. May play a role in neuronal differentiation.
Anti-EFHD1 -http://www.stjohnslabs.com/efhd1-antibody-p-
98622
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Factor H is a member of the regulators of complement activation family and is a complement control protein. It is a large (155 kilodaltons), soluble glycoprotein that circulates in human plasma (at typical concentrations of 200–300 micrograms per milliliter). Its principal function is to regulate the Alternative Pathway of the complement system, ensuring that the complement system is directed towards pathogens or other dangerous material and does not damage host tissue. Factor H regulates complement activation on self cells and surfaces by possessing both cofactor activity for the Factor I mediated C3b cleavage, and decay accelerating activity against the alternative pathway C3-convertase, C3bBb. Factor H exerts its protective action on self cells and self surfaces but not on the surfaces of bacteria or viruses. This is thought to be the result of Factor H having the ability to adopt either different conformations with lower or higher activity. The lower activity conformation is the predominant form in solution and is sufficient to control fluid phase amplification. The more active conformation is thought to be induced when Factor H binds to glycosaminoglycans (GAGs) and or sialic acids that are generally present on host cells but not, normally, on pathogen surfaces ensuring that self surfaces are protected whilst complement proceeds unabated on foreign surfaces.
Anti-FH -http://www.stjohnslabs.com/fh-antibody-p-98610
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The protein encoded by this gene was originally identified as an ovarian tumor antigen monitored in ovarian cancer. The encoded protein contains a B-box/coiled coil motif, which is present in many genes with transformation potential. This gene is located on a region of chromosome 17q21.1 that is in close proximity to tumor suppressor gene BRCA1. Three alternatively spliced variants encoding the same protein have been identified for this gene.[4] One implied function lies in autophagy, where it acts a cargo receptor in selective autophagy.
Anti-NBR1 - http://www.stjohnslabs.com/anti-nbr1-antibody?filter_name=STJ98902
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Seems to be involved in transcriptional silencing in heterochromatin-like complexes. Recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression. May contribute to the association of the heterochromatin with the inner nuclear membrane through its interaction with lamin B receptor (LBR). Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. Contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation, mediates the recruitment of the methyltransferases SUV39H1 and/or SUV39H2 by the PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1.
Anti-HP-1γ-http://www.stjohnslabs.com/anti-hp-1g-antibody?filter_name=STJ98892
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress. Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3'. Activity suppressed by insulin. Main regulator of redox balance and osteoblast numbers and controls bone mass. Orchestrates the endocrine function of the skeleton in regulating glucose metabolism. Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity. Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP. In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC and PCK1. Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and SKT4/MST1. Promotes neural cell death. Mediates insulin action on adipose tissue. Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake. Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells. Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent
Anti-FoxO1-http://www.stjohnslabs.com/foxo1-antibody-p-92348
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Transferrin Antibody...St John's Laboratory Ltd
Transferrins are iron binding transport proteins which can bind two Fe3+ ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation.
Anti-Transferrin-http://www.stjohnslabs.com/transferrin-antibody-p-98689
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Acts as a calcium sensor for mitochondrial flash (mitoflash) activation, an event characterized by stochastic bursts of superoxide production. May play a role in neuronal differentiation.
Anti-EFHD1 -http://www.stjohnslabs.com/efhd1-antibody-p-
98622
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Factor H is a member of the regulators of complement activation family and is a complement control protein. It is a large (155 kilodaltons), soluble glycoprotein that circulates in human plasma (at typical concentrations of 200–300 micrograms per milliliter). Its principal function is to regulate the Alternative Pathway of the complement system, ensuring that the complement system is directed towards pathogens or other dangerous material and does not damage host tissue. Factor H regulates complement activation on self cells and surfaces by possessing both cofactor activity for the Factor I mediated C3b cleavage, and decay accelerating activity against the alternative pathway C3-convertase, C3bBb. Factor H exerts its protective action on self cells and self surfaces but not on the surfaces of bacteria or viruses. This is thought to be the result of Factor H having the ability to adopt either different conformations with lower or higher activity. The lower activity conformation is the predominant form in solution and is sufficient to control fluid phase amplification. The more active conformation is thought to be induced when Factor H binds to glycosaminoglycans (GAGs) and or sialic acids that are generally present on host cells but not, normally, on pathogen surfaces ensuring that self surfaces are protected whilst complement proceeds unabated on foreign surfaces.
Anti-FH -http://www.stjohnslabs.com/fh-antibody-p-98610
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The protein encoded by this gene was originally identified as an ovarian tumor antigen monitored in ovarian cancer. The encoded protein contains a B-box/coiled coil motif, which is present in many genes with transformation potential. This gene is located on a region of chromosome 17q21.1 that is in close proximity to tumor suppressor gene BRCA1. Three alternatively spliced variants encoding the same protein have been identified for this gene.[4] One implied function lies in autophagy, where it acts a cargo receptor in selective autophagy.
Anti-NBR1 - http://www.stjohnslabs.com/anti-nbr1-antibody?filter_name=STJ98902
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Seems to be involved in transcriptional silencing in heterochromatin-like complexes. Recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression. May contribute to the association of the heterochromatin with the inner nuclear membrane through its interaction with lamin B receptor (LBR). Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. Contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation, mediates the recruitment of the methyltransferases SUV39H1 and/or SUV39H2 by the PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1.
Anti-HP-1γ-http://www.stjohnslabs.com/anti-hp-1g-antibody?filter_name=STJ98892
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further NFKBIA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation.
Anti-IκB β-http://www.stjohnslabs.com/ikb-b-antibody-1f3
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML . Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity).
Anti-Catenin-β-http://www.stjohnslabs.com/catenin-b-antibody-
p-99071
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Collagen IV Antibody...St John's Laboratory Ltd
Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. Inhibits expression of hypoxia-inducible factor 1alpha and ERK1/2 and p38 MAPK activation. Ligand for alpha1/beta1 integrin.
Anti-Collagen IV - http://www.stjohnslabs.com/anti-collagen-iv-antibody?filter_name=STJ98907
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Progesterone receptor isoform B (PRB) is involved activation of c-SRC/MAPK signaling on hormone stimulation. / Isoform A: inactive in stimulating c-Src/MAPK signaling on hormone stimulation. / Isoform 4: Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
Anti-PR-http://www.stjohnslabs.com/pr-antibody-p-99016
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.
Anti-PPAR Delta-http://www.stjohnslabs.com/ppar-delta-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-β II tubulin Antibod...St John's Laboratory Ltd
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain (By similarity).
Anti-β II tubulin-http://www.stjohnslabs.com/b-ii-tubulin-antibody-p-98688
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document describes immunohistochemistry protocols for validating an anti-epsilon tubulin antibody in paraffin-embedded tissue samples of human liver, rat lung, kidney, spleen, and mouse lung. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing, and visualization under a microscope. Validation results showed specific staining of epsilon tubulin in the tissue samples.
Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis. Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis. Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules. The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules. May counteract a default induction of apoptosis in G2/M phase. The acetylated form represses STAT3 transactivation of target gene promoters. May play a role in neoplasia. Inhibitor of CASP3 and CASP7. Isoform 2 and isoform 3 do not appear to play vital roles in mitosis. Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform.
Anti-Survivin-http://www.stjohnslabs.com/survivin-antibody-p-99087
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade.
Anti-MEK-1/2-http://www.stjohnslabs.com/mek-12-antibody-p-93086
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain. / Plays a role in apoptosis. Suppression of the anti-apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases.
Anti-CYCS-http://www.stjohnslabs.com/cycs-antibody-p-99070
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Cystatin C Antibody ...St John's Laboratory Ltd
As an inhibitor of cysteine proteinases, this protein is thought to serve an important physiological role as a local regulator of this enzyme activity.
Anti-Cystatin C-http://www.stjohnslabs.com/cystatin-c-antibody-5
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS1 is involved in negative regulation of cytokines that signal through the JAK/STAT3 pathway. Through binding to JAKs, inhibits their kinase activity. In vitro, also suppresses Tec protein-tyrosine activity. Appears to be a major regulator of signaling by interleukin 6 (IL6) and leukemia inhibitory factor (LIF). Regulates interferon-gamma mediated sensory neuron survival (By similarity). Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Seems to recognize JAK2. SOCS1 appears to be a negative regulator in IGF1R signaling pathway.
Anti-SOCS-1-http://www.stjohnslabs.com/socs-1-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation.
Anti-Phospho-ERK 1/2 (Y204)-http://www.stjohnslabs.com/phospho-erk-12-y204-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Phospho-CREB-1 (S133...St John's Laboratory Ltd
Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-133 phosphorylation. Involved in different cellular processes including the synchronization of circadian rhythmicity and the differentiation of adipose cells.
Anti-Phospho-CREB-1 (S133) -http://www.stjohnslabs.com/phospho-creb-1-s133-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Thiol protease that cleaves IL-1 beta between an Asp and an Ala, releasing the mature cytokine which is involved in a variety of inflammatory processes. Important for defense against pathogens. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Can also promote apoptosis. / Strict requirement for an Asp residue at position P1 and has a preferred cleavage sequence of Tyr-Val-Ala-Asp-|-. / Specifically inhibited by the cowpox virus Crma protein.
Anti-Caspase-1-http://www.stjohnslabs.com/caspase-1-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key regulator of mitochondrial calcium uniporter (MCU) required to increase calcium uptake by MCU when cytoplasmic calcium is high. MICU1 and MICU2 form a disulfide-linked heterodimer that stimulate and inhibit MCU activity, respectively. MICU1 acts as a stimulator of MCU that senses calcium level via its EF-hand domains: enhances MCU opening at high Ca2+ concentration, allowing a rapid response of mitochondria to Ca2+ signals generated in the cytoplasm. Regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake. Induces T-helper 1-mediated autoreactivity, which is accompanied by the release of IFNG.
Anti-MICU1-http://www.stjohnslabs.com/micu1-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes a standardized immunohistochemistry protocol for validating an anti-CYCS polyclonal antibody in rat and mouse tissues including heart, lung, and kidney. The protocol involves tissue processing, antigen retrieval using citric acid, blocking endogenous peroxidase activity, blocking with BSA, incubating with the primary antibody overnight at 4°C, incubating with an HRP-labeled secondary antibody, performing DAB staining, hematoxylin counterstaining, dehydration, clearing, and visualization under a microscope. Results are reported for the antibody validation in paraffin-embedded sections of rat heart, lung, kidney and mouse heart and lung tissues.
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
Anti-Tau- http://www.stjohnslabs.com/anti-tau-antibody?filter_name=STJ98827
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes an immunohistochemistry protocol for validating an anti-HMG-1 polyclonal antibody in paraffin-embedded tissue samples of human uterus, rat lung, kidney, mouse heart and lung. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing and visualization under a microscope. The protocol is used to test the antibody specificity and sensitivity in different species.
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells. Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus . Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types .
Anti-TGFβ1-http://www.stjohnslabs.com/tgfb1-antibody-p-94593
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document summarizes key findings from an analysis of antibody market research data from 2011-2016:
- The United States has the largest antibody market, followed by China. Cancer research generates the most demand for antibodies targeting proteins like Akt, actin, and GAPDH.
- Western blot and immunohistochemistry are the most common antibody applications. Monoclonal antibodies account for 63% of the market.
- The top antibody vendors cited are Santa Cruz Biotechnology, Cell Signaling Technology, and Thermo Fisher Scientific's Invitrogen brand. Journal publications in PLoS ONE and Journal of Biological Chemistry provide many antibody citations.
Proteintech: The Benchmark in Antibodies.
Learn more about Mitochondrial research, including:
- Mitochondrial markers
- The citric acid cycle
- Mitochondrial Respiratory Complexes
- Mitochondrial Fission & Fusion
and more...
Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further NFKBIA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation.
Anti-IκB β-http://www.stjohnslabs.com/ikb-b-antibody-1f3
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML . Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity).
Anti-Catenin-β-http://www.stjohnslabs.com/catenin-b-antibody-
p-99071
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Collagen IV Antibody...St John's Laboratory Ltd
Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. Inhibits expression of hypoxia-inducible factor 1alpha and ERK1/2 and p38 MAPK activation. Ligand for alpha1/beta1 integrin.
Anti-Collagen IV - http://www.stjohnslabs.com/anti-collagen-iv-antibody?filter_name=STJ98907
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Progesterone receptor isoform B (PRB) is involved activation of c-SRC/MAPK signaling on hormone stimulation. / Isoform A: inactive in stimulating c-Src/MAPK signaling on hormone stimulation. / Isoform 4: Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
Anti-PR-http://www.stjohnslabs.com/pr-antibody-p-99016
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.
Anti-PPAR Delta-http://www.stjohnslabs.com/ppar-delta-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-β II tubulin Antibod...St John's Laboratory Ltd
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain (By similarity).
Anti-β II tubulin-http://www.stjohnslabs.com/b-ii-tubulin-antibody-p-98688
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document describes immunohistochemistry protocols for validating an anti-epsilon tubulin antibody in paraffin-embedded tissue samples of human liver, rat lung, kidney, spleen, and mouse lung. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing, and visualization under a microscope. Validation results showed specific staining of epsilon tubulin in the tissue samples.
Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis. Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis. Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules. The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules. May counteract a default induction of apoptosis in G2/M phase. The acetylated form represses STAT3 transactivation of target gene promoters. May play a role in neoplasia. Inhibitor of CASP3 and CASP7. Isoform 2 and isoform 3 do not appear to play vital roles in mitosis. Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform.
Anti-Survivin-http://www.stjohnslabs.com/survivin-antibody-p-99087
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade.
Anti-MEK-1/2-http://www.stjohnslabs.com/mek-12-antibody-p-93086
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain. / Plays a role in apoptosis. Suppression of the anti-apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases.
Anti-CYCS-http://www.stjohnslabs.com/cycs-antibody-p-99070
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Cystatin C Antibody ...St John's Laboratory Ltd
As an inhibitor of cysteine proteinases, this protein is thought to serve an important physiological role as a local regulator of this enzyme activity.
Anti-Cystatin C-http://www.stjohnslabs.com/cystatin-c-antibody-5
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS1 is involved in negative regulation of cytokines that signal through the JAK/STAT3 pathway. Through binding to JAKs, inhibits their kinase activity. In vitro, also suppresses Tec protein-tyrosine activity. Appears to be a major regulator of signaling by interleukin 6 (IL6) and leukemia inhibitory factor (LIF). Regulates interferon-gamma mediated sensory neuron survival (By similarity). Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Seems to recognize JAK2. SOCS1 appears to be a negative regulator in IGF1R signaling pathway.
Anti-SOCS-1-http://www.stjohnslabs.com/socs-1-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation.
Anti-Phospho-ERK 1/2 (Y204)-http://www.stjohnslabs.com/phospho-erk-12-y204-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Phospho-CREB-1 (S133...St John's Laboratory Ltd
Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-133 phosphorylation. Involved in different cellular processes including the synchronization of circadian rhythmicity and the differentiation of adipose cells.
Anti-Phospho-CREB-1 (S133) -http://www.stjohnslabs.com/phospho-creb-1-s133-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Thiol protease that cleaves IL-1 beta between an Asp and an Ala, releasing the mature cytokine which is involved in a variety of inflammatory processes. Important for defense against pathogens. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Can also promote apoptosis. / Strict requirement for an Asp residue at position P1 and has a preferred cleavage sequence of Tyr-Val-Ala-Asp-|-. / Specifically inhibited by the cowpox virus Crma protein.
Anti-Caspase-1-http://www.stjohnslabs.com/caspase-1-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key regulator of mitochondrial calcium uniporter (MCU) required to increase calcium uptake by MCU when cytoplasmic calcium is high. MICU1 and MICU2 form a disulfide-linked heterodimer that stimulate and inhibit MCU activity, respectively. MICU1 acts as a stimulator of MCU that senses calcium level via its EF-hand domains: enhances MCU opening at high Ca2+ concentration, allowing a rapid response of mitochondria to Ca2+ signals generated in the cytoplasm. Regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake. Induces T-helper 1-mediated autoreactivity, which is accompanied by the release of IFNG.
Anti-MICU1-http://www.stjohnslabs.com/micu1-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes a standardized immunohistochemistry protocol for validating an anti-CYCS polyclonal antibody in rat and mouse tissues including heart, lung, and kidney. The protocol involves tissue processing, antigen retrieval using citric acid, blocking endogenous peroxidase activity, blocking with BSA, incubating with the primary antibody overnight at 4°C, incubating with an HRP-labeled secondary antibody, performing DAB staining, hematoxylin counterstaining, dehydration, clearing, and visualization under a microscope. Results are reported for the antibody validation in paraffin-embedded sections of rat heart, lung, kidney and mouse heart and lung tissues.
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
Anti-Tau- http://www.stjohnslabs.com/anti-tau-antibody?filter_name=STJ98827
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes an immunohistochemistry protocol for validating an anti-HMG-1 polyclonal antibody in paraffin-embedded tissue samples of human uterus, rat lung, kidney, mouse heart and lung. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing and visualization under a microscope. The protocol is used to test the antibody specificity and sensitivity in different species.
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells. Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus . Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types .
Anti-TGFβ1-http://www.stjohnslabs.com/tgfb1-antibody-p-94593
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document summarizes key findings from an analysis of antibody market research data from 2011-2016:
- The United States has the largest antibody market, followed by China. Cancer research generates the most demand for antibodies targeting proteins like Akt, actin, and GAPDH.
- Western blot and immunohistochemistry are the most common antibody applications. Monoclonal antibodies account for 63% of the market.
- The top antibody vendors cited are Santa Cruz Biotechnology, Cell Signaling Technology, and Thermo Fisher Scientific's Invitrogen brand. Journal publications in PLoS ONE and Journal of Biological Chemistry provide many antibody citations.
Proteintech: The Benchmark in Antibodies.
Learn more about Mitochondrial research, including:
- Mitochondrial markers
- The citric acid cycle
- Mitochondrial Respiratory Complexes
- Mitochondrial Fission & Fusion
and more...
This document provides guidance on optimizing immunofluorescence staining techniques. It discusses fundamental principles, sample preparation including fixation, controls, troubleshooting tips, and visualization methods. The key steps covered are fixation to preserve cell structure while maintaining epitopes, controlling for autofluorescence, choosing direct or indirect visualization depending on the target antigen expression level, and selecting mounting media based on the specific application. Proper controls and troubleshooting recommendations are also outlined to ensure specific and high quality staining results.
The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Progesterone receptor isoform B (PRB) is involved activation of c-SRC/MAPK signaling on hormone stimulation. / Isoform A: inactive in stimulating c-Src/MAPK signaling on hormone stimulation. / Isoform 4: Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
Anti-PR -http://www.stjohnslabs.com/pr-antibody-p-99016
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
CD15 mediates phagocytosis and chemotaxis, found on neutrophils; expressed in patients with Hodgkin disease, some B-cell chronic lymphocytic leukemias, acute lymphoblastic leukemias, and most acute nonlymphocytic leukemias. It is also called Lewis x and SSEA-1 (stage-specific embryonic antigen 1) and represents a marker for murine pluripotent stem cells, in which it plays an important role in adhesion and migration of the cells in the preimplantation embryo. It is synthezised by FUT4 (fucosyltransferase 4) and FUT9.
Anti-CD15 -http://www.stjohnslabs.com/cd15-antibody-p-98642
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
Anti-α skeletal muscle actin -http://www.stjohnslabs.com/a-skeletal-muscle-actin-antibody-p-98686
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunofluorescence Antibody Validation Report for Anti-β-tubulin (HRP)Antibo...St John's Laboratory Ltd
To form microtubules, the dimers of α- and β-tubulin bind to GTP and assemble onto the (+) ends of microtubules while in the GTP-bound state. The β-tubulin subunit is exposed on the plus end of the microtubule while the α-tubulin subunit is exposed on the minus end. After the dimer is incorporated into the microtubule, the molecule of GTP bound to the β-tubulin subunit eventually hydrolyzes into GDP through inter-dimer contacts along the microtubule protofilament. Whether the β-tubulin member of the tubulin dimer is bound to GTP or GDP influences the stability of the dimer in the microtubule. Dimers bound to GTP tend to assemble into microtubules, while dimers bound to GDP tend to fall apart; thus, this GTP cycle is essential for the dynamic instability of the microtubule.
Anti-β-tubulin (HRP)-http://www.stjohnslabs.com/b-tubulin-antibody-hrp-p-99128
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3. Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones. AIM-100 (4-amino-5, 6-biaryl-furo[2, 3-d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-269. Inhibits the binding of the Tyr-269 phosphorylated form to androgen-responsive enhancers (AREs) and its transcriptional activity.
Anti-AR -http://www.stjohnslabs.com/ar-antibody-p-98868
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain. / Plays a role in apoptosis. Suppression of the anti-apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases.
Anti-CYCS -http://www.stjohnslabs.com/cycs-antibody-p-99070
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B.
Anti-HDAC1 -http://www.stjohnslabs.com/hdac1-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This antibody validation report describes the testing of an anti-PPAR Delta monoclonal antibody (clone 2F9) on rat and mouse spleen tissue samples. The report details the immunofluorescence protocol used, including tissue processing, antigen retrieval, primary and secondary antibody incubations, DAPI counterstaining, mounting, and visualization under a fluorescence microscope. Images show the distribution of the target protein in red fluorescence and DAPI nuclear counterstain in blue.
Immunofluorescence Antibody Validation Report for Anti-Cystatin C Antibody (S...St John's Laboratory Ltd
Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function. Recently, it has been studied for its role in predicting new-onset or deteriorating cardiovascular disease. It also seems to play a role in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the DNA) produce cystatin C as a chain of 120 amino acids. It is found in virtually all tissues and body fluids. It is a potent inhibitor of lysosomal proteinases (enzymes from a special subunit of the cell that break down proteins) and probably one of the most important extracellular inhibitors of cysteine proteases (it prevents the breakdown of proteins outside the cell by a specific type of protein degrading enzymes). Cystatin C belongs to the type 2 cystatin gene family.
Anti-Cystatin C -http://www.stjohnslabs.com/cystatin-c-
antibody-5
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function.
Anti-HSP90β -http://www.stjohnslabs.com/hsp90b-antibody-p-98667
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML . Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle.
Anti-Catenin-β -http://www.stjohnslabs.com/catenin-b-antibody-p-99071
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. Binds to DNA and to DNA ligase IV (LIG4). The LIG4-XRCC4 complex is responsible for the NHEJ ligation step, and XRCC4 enhances the joining activity of LIG4. Binding of the LIG4-XRCC4 complex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends.
Anti-XRCC4 -http://www.stjohnslabs.com/xrcc4-antibody-p-98623
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The report describes the validation of an anti-IκB β monoclonal antibody (clone 1F3) for use in immunofluorescence applications. The antibody was tested on human liver cancer tissue and mouse testis tissue. Tissue samples underwent antigen retrieval and were incubated with the primary antibody overnight at 4°C followed by a fluorescent secondary antibody at room temperature for 50 minutes. Samples were counterstained with DAPI and visualized under a fluorescence microscope. Results indicate the antibody specifically labeled target tissue as expected.
Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and activates the promoters of the genes for some small nuclear RNAs (snRNA) and of genes such as those for histone H2B and immunoglobulins. Modulates transcription transactivation by NR3C1, AR and PGR (By similarity). In case of human herpes simplex virus (HSV) infection, POU2F1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and HCFC1 thereby enabling the transcription of the viral immediate early genes.
Anti-OCT1 -http://www.stjohnslabs.com/oct1-antibody-p-98626
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Ubiquitin: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in lysosomal degradation; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B.
Anti-Ub -http://www.stjohnslabs.com/ub-antibody-p-98871
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Induces cartilage and bone formation . Stimulates the differentiation of myoblasts into osteoblasts via the EIF2AK3-EIF2A- ATF4 pathway. BMP2 activation of EIF2AK3 stimulates phosphorylation of EIF2A which leads to increased expression of ATF4 which plays a central role in osteoblast differentiation. In addition stimulates TMEM119, which upregulates the expression of ATF4 .
Anti-BMP-2 -http://www.stjohnslabs.com/bmp-2-antibody-p-98981
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This report describes an immunofluorescence analysis of an anti-MICU1 monoclonal antibody on human appendix tissue. The tissue was processed using antigen retrieval, blocking, and staining with the primary and secondary antibodies overnight and 50 minutes respectively. It was then counterstained with DAPI and mounted for visualization under a fluorescence microscope. The report provides details on the antibody, tissue, staining protocol, and microscope used for analysis.
Multifunctional transcription factor in ER stress response. Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress. Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes. Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes. Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L. Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG).
Anti-CHOP-http://www.stjohnslabs.com/chop-antibody-2
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Accelerates programmed cell death by binding to, and antagonizing the apoptosis repressor BCL2 or its adenovirus homolog E1B 19k protein. Under stress conditions, undergoes a conformation change that causes translocation to the mitochondrion membrane, leading to the release of cytochrome c that then triggers apoptosis. Promotes activation of CASP3, and thereby apoptosis.
Anti-Bax-http://www.stjohnslabs.com/bax-antibody-2
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Has 2-hydroxyacid oxidase activity. Most active on the 2-carbon substrate glycolate, but is also active on 2-hydroxy fatty acids, with high activity towards 2-hydroxy palmitate and 2-hydroxy octanoate. / (S)-2-hydroxy acid + O2 = 2-oxo acid + H2O2.
Anti-HAO1-http://www.stjohnslabs.com/hao1-antibody-p-99046
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity (By similarity). Involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Recruits CTNNB1 to caveolar membranes and may regulate CTNNB1-mediated signaling through the Wnt pathway. Negatively regulates TGFB1-mediated activation of SMAD2/3 by mediating the internalization of TGFBR1 from membrane rafts leading to its subsequent degradation .
Anti-Caveolin-1-http://www.stjohnslabs.com/caveolin-1-antibody-p-91510
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document describes the protocol for performing immunohistochemistry on paraffin-embedded tissue samples using an anti-Nrf2 polyclonal antibody. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing and mounting. The same protocol is applied to human uterus, lung, lung cancer, rat lung and mouse lung tissues to validate the use of the anti-Nrf2 antibody for immunohistochemistry.
Glial fibrillary acidic protein is an intermediate filament (IF) protein that is expressed by numerous cell types of the central nervous system (CNS) including astrocytes and ependymal cells. GFAP has also been found to be expressed in glomeruli and peritubular fibroblasts taken from rat kidneys Leydig cells of the testis in both hamsters and humans, human keratinocytes, human osteocytes and chondrocytes and stellate cells of the pancreas and liver in rats. First described in 1971, GFAP is a type III IF protein that maps, in humans, to 17q21.[13] It is closely related to its non-epithelial family members, vimentin, desmin, and peripherin, which are all involved in the structure and function of the cell’s cytoskeleton. GFAP is thought to help to maintain astrocyte mechanical strength,[14] as well as the shape of cells but its exact function remains poorly understood, despite the number of studies using it as a cell marker.
Anti-GFAP -http://www.stjohnslabs.com/gfap-antibody-p-98596
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes the immunohistochemistry protocol used to validate an anti-SDF-1 polyclonal antibody in paraffin-embedded tissue samples of human uterus, rat lung, and mouse lung. The protocol involves tissue processing, antigen retrieval, blocking endogenous peroxidase, primary antibody incubation, secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing, and visualization under a microscope. Validation reports are provided for the antibody tested in each tissue sample.
Immunohistochemistry Antibody Validation Report for Anti-VE-Cadherin Antibody...St John's Laboratory Ltd
The document describes an immunohistochemistry protocol for validating an anti-VE-Cadherin antibody in paraffin-embedded tissue samples from human liver, rat lung, spleen and mouse liver, kidney. The protocol involves tissue processing, antigen retrieval, blocking, primary and secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing and visualization under a microscope. Validation reports are provided for the antibody tested on each species and tissue.
Ubiquitin-like modifier involved in formation of autophagosomal vacuoles (autophagosomes) . Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation .
Anti-LC3A-http://www.stjohnslabs.com/lc3a-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation.
Anti-Rock-1-http://www.stjohnslabs.com/rock-1-antibody-p-94232
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1. Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu2+-mediated low-density lipoprotein oxidation.
Anti-Amyloid-β-http://www.stjohnslabs.com/amyloid-v-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
The document describes immunohistochemistry protocols for testing a desmin monoclonal antibody (clone 1B12) on paraffin-embedded tissue samples from human lung, rat heart, spleen and mouse lung, spleen. The protocol involves tissue processing, antigen retrieval using citric acid, blocking endogenous peroxidase, primary antibody incubation with the desmin antibody, secondary antibody incubation, DAB staining, hematoxylin counterstaining, dehydration, clearing and visualization under a microscope. The protocols are provided to validate the desmin antibody for immunohistochemistry applications on the specified species and tissue types.
Accessory protein for MHC class-II antigen/T-cell receptor interaction. May regulate T-cell activation. Induces the aggregation of lipid rafts. / (Microbial infection) Acts as a receptor for human immunodeficiency virus-1 . Down-regulated by HIV-1 Vpu . Acts as a receptor for Human Herpes virus 7/HHV-7.
Anti-CD4 -http://www.stjohnslabs.com/cd4-antibody-p-98607
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Collagen I Antibody ...St John's Laboratory Ltd
Collagen is a protein that strengthens and supports many tissues in the body, including cartilage, bone, tendon, skin and the white part of the eye (sclera). The COL1A1 gene produces a component of type I collagen, called the pro-alpha1(I) chain. This chain combines with another pro-alpha1(I) chain and also with a pro-alpha2(I) chain (produced by the COL1A2 gene) to make a molecule of type I procollagen. These triple-stranded, rope-like procollagen molecules must be processed by enzymes outside the cell. Once these molecules are processed, they arrange themselves into long, thin fibrils that cross-link to one another in the spaces around cells. The cross-links result in the formation of very strong mature type I collagen fibers. Collagenous function includes rigidity and elasticity.
Anti-Collagen I - http://www.stjohnslabs.com/anti-collagen-i-antibody-p-104886?filter_name=STJ98915
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
CD2 interacts with lymphocyte function-associated antigen (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function.
Anti-CD2-http://www.stjohnslabs.com/cd2-antibody-p-98606
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation.
Anti-MDM2-http://www.stjohnslabs.com/mdm2-antibody-p-94965
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Drug efflux transporter present in a number of stem cells that acts as a regulator of cellular differentiation. Able to mediate efflux from cells of the rhodamine dye and of the therapeutic drug doxorubicin. Specifically present in limbal stem cells, where it plays a key role in corneal development and repair.
Anti-ABCB5-http://www.stjohnslabs.com/abcb5-antibody-p-98611
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energetics and participates in the coordination of several separated cellular functions such as cell cycle, response to DNA damage, metobolism, apoptosis and autophagy. Can modulate chromatin function through deacetylation of histones and can promote alterations in the methylation of histones and DNA, leading to transcriptional repression. Deacetylates a broad range of transcription factors and coregulators, thereby regulating target gene expression positively and negatively. Serves as a sensor of the cytosolic ratio of NAD+/NADH which is altered by glucose deprivation and metabolic changes associated with caloric restriction. Is essential in skeletal muscle cell differentiation and in response to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves 5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT).
Anti-SIRT1-http://www.stjohnslabs.com/sirt1-antibody-p-94333
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Claudins are a family of proteins that are the most important components of the tight junctions, where they establish the paracellular barrier that controls the flow of molecules in the intercellular space between the cells of an epithelium. They have four transmembrane domains, with the N-terminus and the C-terminus in the cytoplasm.
Anti-Claudin-5 -http://www.stjohnslabs.com/claudin-5-antibody-p-95192
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Similar to Immunohistochemistry Antibody Validation Report for Anti-Ubiquitin Antibody (STJ97742) (19)
G protein-coupled receptor that probably associates with the patched protein (PTCH) to transduce the hedgehog's proteins signal. Binding of sonic hedgehog (SHH) to its receptor patched is thought to prevent normal inhibition by patched of smoothened (SMO). Required for the accumulation of KIF7 and GLI3 in the cilia.
Anti-Smo antibody (STJ95710): http://www.stjohnslabs.com/smo-antibody-p-94371?filter_name=STJ95710
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Western Blot Customer Review Anti Glucocorticoid Receptor antibody (STJ97101)St John's Laboratory Ltd
Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling . Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity). Has transcriptional activation and repression activity . Mediates glucocorticoid-induced apoptosis . Promotes accurate chromosome segregation during mitosis . May act as a tumor suppressor . May play a negative role in adipogenesis through the regulation of lipolytic and antilipogenic gene expression (By similarity). / Isoform Beta: Acts as a dominant negative inhibitor of isoform Alpha . Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed.
Join our Antibody Validation Project: http://www.stjohnslabs.com/services/antibody-validation
Anti glucocorticoid receptor antibody (STJ97101):
http://www.stjohnslabs.com/glucocorticoid-receptor-antibody-p-98736?filter_name=STJ97101
Western Blot Customer Review Anti-Phospho-Cofilin (S3) Antibody (STJ90230)St John's Laboratory Ltd
Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity. Regulates actin cytoskeleton dynamics. Important for normal progress through mitosis and normal cytokinesis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required for the up-regulation of atypical chemokine receptor ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation.
Anti-Phospho-Cofilin (S3) -http://www.stjohnslabs.com/phospho-cofilin-s3-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This June, Dr. Byron Baron from the University of Malta, Malta, is our Scientist of the Month! He's shared with us his research highlights, his current projects and some comments on the biotechnology industry.
Want to be our Scientist of the Month? Contact info@stjohnslabs.com
Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex.
Anti-WAVE2 -http://www.stjohnslabs.com/wave2-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Implicated in synaptic vesicle endocytosis. May recruit other proteins to membranes with high curvature.
Brain, mostly in frontal cortex. Expressed at high level in fetal cerebellum.
Anti-Endophilin I -http://www.stjohnslabs.com/endophilin-i-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain. TUBB3 plays a critical role in proper axon guidance and mantainance.
Anti-β-tubulin -http://www.stjohnslabs.com/b-tubulin-antibody-p-98672
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Most upstream protease of the activation cascade of caspases responsible for the TNFRSF6/FAS mediated and TNFRSF1A induced cell death. Binding to the adapter molecule FADD recruits it to either receptor. The resulting aggregate called death-inducing signaling complex (DISC) performs CASP8 proteolytic activation. The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases. Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC. Cleaves and activates CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10. May participate in the GZMB apoptotic pathways. Cleaves ADPRT. Hydrolyzes the small-molecule substrate, Ac-Asp-Glu-Val-Asp-|-AMC. Likely target for the cowpox virus CRMA death inhibitory protein. Isoform 5, isoform 6, isoform 7 and isoform 8 lack the catalytic site and may interfere with the pro-apoptotic activity of the complex. / Strict requirement for Asp at position P1 and has a preferred cleavage sequence of (Leu/Asp/Val)-Glu-Thr-Asp-|-(Gly/Ser/Ala). / Inhibited by the effector protein NleF that is produced by pathogenic E.coli; this inhibits apoptosis.
Anti-Caspase-8-http://www.stjohnslabs.com/caspase-8-antibody-p-99045
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Tubulin is the major constituent of microtubules. The gamma chain is found at microtubule organizing centers (MTOC) such as the spindle poles or the centrosome. Pericentriolar matrix component that regulates alpha/beta chain minus-end nucleation, centrosome duplication and spindle formation.
Anti-Gamma Tubulin-http://www.stjohnslabs.com/gamma-tubulin-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process. Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage. Does not have protein kinase activity.
Anti-phospho-MLKL (S358)-http://www.stjohnslabs.com/phospho-mlkl-s358-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
This document summarizes the immunohistochemistry protocol used to analyze ERK1 protein expression in human uterus tissue samples. Key steps included: antigen retrieval using citric acid; blocking of endogenous peroxidase; primary antibody incubation with anti-ERK1 antibody overnight at 4°C; secondary antibody incubation at room temperature for 30 minutes; DAB staining to visualize positive results; hematoxylin counterstaining; dehydration and clearing of slides; and visualization under a microscope. The protocol validated that the anti-ERK1 antibody specifically labeled ERK1 protein in human uterus tissue as expected.
Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation.
Anti-PDGFRα-http://www.stjohnslabs.com/pdgfra-antibody-2
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release .
Anti-Bcl-2-http://www.stjohnslabs.com/bcl-2-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Alpha-actin-2 also known as actin, aortic smooth muscle or alpha smooth muscle actin (α-SMA, SMactin, alpha-SM-actin, ASMA) is a protein that in humans is encoded by the ACTA2 gene located on 10q22-q24. Actin alpha 2, the human aortic smooth muscle actin gene, is one of six different actin isoforms which have been identified. Actins are highly conserved proteins that are involved in cell motility, structure and integrity. Alpha actins are a major constituent of the contractile apparatus. Alpha-smooth muscle actin (α-SMA) is commonly used as a marker of myofibroblast formation.
Anti-α-SMA -http://www.stjohnslabs.com/a-sma-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F1 binds preferentially RB1 in a cell-cycle dependent manner. It can mediate both cell proliferation and TP53/p53-dependent apoptosis. Blocks adipocyte differentiation by binding to specific promoters repressing CEBPA binding to its target gene promoters . / BIRC2/c-IAP1 stimulates its transcriptional activity.
Anti-E2F-1-http://www.stjohnslabs.com/e2f-1-antibody-1
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunohistochemistry Antibody Validation Report for Anti-Annexin I Antibody (...St John's Laboratory Ltd
Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity. Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Promotes resolution of inflammation and wound healing. Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades. Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors.
Anti-Annexin I - http://www.stjohnslabs.com/anti-annexin-i-antibody?filter_name=STJ98699
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transthyretin (TTR) is a transport protein in the serum and cerebrospinal fluid that carries the thyroid hormone thyroxine (T4) and retinol-binding protein bound to retinol. This is how transthyretin gained its name: transports thyroxine and retinol. The liver secretes transthyretin into the blood, and the choroid plexus secretes TTR into the cerebrospinal fluid.
TTR was originally called prealbumin(or thyroxine-binding prealbumin) because it ran faster than albumin on electrophoresis gels.
Anti-TTR - http://www.stjohnslabs.com/anti-ttr-antibody?filter_name=STJ98876
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins.
Anti-HP-1α - http://www.stjohnslabs.com/anti-hp-1a-antibody?filter_name=STJ98895
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is essential for its function. The ATG12-ATG5 conjugate acts as an E3-like enzyme which is required for lipidation of ATG8 family proteins and their association to the vesicle membranes. Involved in mitochondrial quality control after oxidative damage, and in subsequent cellular longevity. The ATG12-ATG5 conjugate also negatively regulates the innate antiviral immune response by blocking the type I IFN production pathway through direct association with RARRES3 and MAVS. Also plays a role in translation or delivery of incoming viral RNA to the translation apparatus.
Anti-ATG5 - http://www.stjohnslabs.com/anti-atg5-antibody-p-104935?filter_name=STJ98903
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
E1-like activating enzyme involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Required for mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Modulates p53/TP53 activity to regulate cell cycle and survival during metabolic stress. Plays also a key role in the maintenance of axonal homeostasis, the prevention of axonal degeneration, the maintenance of hematopoietic stem cells, the formation of Paneth cell granules, as well as in adipose differentiation.
Anti-ATG7 - http://www.stjohnslabs.com/anti-atg7-antibody?filter_name=STJ98914
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Sérgio Sacani
Context. The observation of several L-band emission sources in the S cluster has led to a rich discussion of their nature. However, a definitive answer to the classification of the dusty objects requires an explanation for the detection of compact Doppler-shifted Brγ emission. The ionized hydrogen in combination with the observation of mid-infrared L-band continuum emission suggests that most of these sources are embedded in a dusty envelope. These embedded sources are part of the S-cluster, and their relationship to the S-stars is still under debate. To date, the question of the origin of these two populations has been vague, although all explanations favor migration processes for the individual cluster members. Aims. This work revisits the S-cluster and its dusty members orbiting the supermassive black hole SgrA* on bound Keplerian orbits from a kinematic perspective. The aim is to explore the Keplerian parameters for patterns that might imply a nonrandom distribution of the sample. Additionally, various analytical aspects are considered to address the nature of the dusty sources. Methods. Based on the photometric analysis, we estimated the individual H−K and K−L colors for the source sample and compared the results to known cluster members. The classification revealed a noticeable contrast between the S-stars and the dusty sources. To fit the flux-density distribution, we utilized the radiative transfer code HYPERION and implemented a young stellar object Class I model. We obtained the position angle from the Keplerian fit results; additionally, we analyzed the distribution of the inclinations and the longitudes of the ascending node. Results. The colors of the dusty sources suggest a stellar nature consistent with the spectral energy distribution in the near and midinfrared domains. Furthermore, the evaporation timescales of dusty and gaseous clumps in the vicinity of SgrA* are much shorter ( 2yr) than the epochs covered by the observations (≈15yr). In addition to the strong evidence for the stellar classification of the D-sources, we also find a clear disk-like pattern following the arrangements of S-stars proposed in the literature. Furthermore, we find a global intrinsic inclination for all dusty sources of 60 ± 20◦, implying a common formation process. Conclusions. The pattern of the dusty sources manifested in the distribution of the position angles, inclinations, and longitudes of the ascending node strongly suggests two different scenarios: the main-sequence stars and the dusty stellar S-cluster sources share a common formation history or migrated with a similar formation channel in the vicinity of SgrA*. Alternatively, the gravitational influence of SgrA* in combination with a massive perturber, such as a putative intermediate mass black hole in the IRS 13 cluster, forces the dusty objects and S-stars to follow a particular orbital arrangement. Key words. stars: black holes– stars: formation– Galaxy: center– galaxies: star formation
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
Embracing Deep Variability For Reproducibility and Replicability
Abstract: Reproducibility (aka determinism in some cases) constitutes a fundamental aspect in various fields of computer science, such as floating-point computations in numerical analysis and simulation, concurrency models in parallelism, reproducible builds for third parties integration and packaging, and containerization for execution environments. These concepts, while pervasive across diverse concerns, often exhibit intricate inter-dependencies, making it challenging to achieve a comprehensive understanding. In this short and vision paper we delve into the application of software engineering techniques, specifically variability management, to systematically identify and explicit points of variability that may give rise to reproducibility issues (eg language, libraries, compiler, virtual machine, OS, environment variables, etc). The primary objectives are: i) gaining insights into the variability layers and their possible interactions, ii) capturing and documenting configurations for the sake of reproducibility, and iii) exploring diverse configurations to replicate, and hence validate and ensure the robustness of results. By adopting these methodologies, we aim to address the complexities associated with reproducibility and replicability in modern software systems and environments, facilitating a more comprehensive and nuanced perspective on these critical aspects.
https://hal.science/hal-04582287
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
Immunohistochemistry Antibody Validation Report for Anti-Ubiquitin Antibody (STJ97742)
1. Figure:
Immunohistochemical
analysis of paraffin
embedded Human
Tonsil tissue. 1:
Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-a Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue TONSIL
ANTIBODY VALIDATION REPORT
a. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
51. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
52. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
53. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
54. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
55. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
45.
46. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
47. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
48. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
49. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
50. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
2. Figure:
Immunohistochemical
analysis of paraffin
embedded Human colon
tissue. 1: Ubiquitin
Mouse Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-b Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue COLON
ANTIBODY VALIDATION REPORT
a. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
40. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
41. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
42. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
43. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
44. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
34.
35. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
36. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
37. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
38. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
39. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
3. Figure:
Immunohistochemical
analysis of paraffin
embedded Human liver
tissue. 1: Ubiquitin
Mouse Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-c Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue LIVER
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
29. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
30. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
31. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
32. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
33. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
23.
24. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
25. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
26. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
27. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
28. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
4. Figure:
Immunohistochemical
analysis of paraffin
embedded Human liver
cancer tissue. 1:
Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-d Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue LIVER CANCER
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
18. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
19. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
20. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
21. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
22. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
12.
13. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
14. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
15. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
16. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
17. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
5. Figure:
Immunohistochemical
analysis of paraffin
embedded Human
stomach tissue. 1:
Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-e Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue STOMACH
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
7. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
8. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
9. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
10. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
11. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
1.
2. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
3. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
4. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
5. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
6. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
6. Figure:
Immunohistochemical
analysis of paraffin
embedded Human
stomach cancer tissue.
1: Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-f Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species HUMAN Testing Tissue STOMACH CANCER
ANTIBODY VALIDATION REPORT
c. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
56. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
57. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
58. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
59. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
60. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
61.
62. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
63. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
64. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
65. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
66. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
7. Figure:
Immunohistochemical
analysis of paraffin
embedded Rat lung
tissue. 1: Ubiquitin
Mouse Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-g Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species RAT Testing Tissue LUNG
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
67. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
68. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
69. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
70. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
71. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
72.
73. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
74. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
75. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
76. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
77. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
8. Figure:
Immunohistochemical
analysis of paraffin
embedded Rat kidney
tissue. 1: Ubiquitin
Mouse Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-h Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species RAT Testing Tissue KIDNEY
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
78. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
79. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
80. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
81. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
82. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
83.
84. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
85. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
86. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
87. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
88. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
9. Figure:
Immunohistochemical
analysis of paraffin
embedded Rat spleen
tissue. 1: Ubiquitin
Mouse Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-i Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species RAT Testing Tissue SPLEEN
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
89. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
90. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
91. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
92. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
93. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
94.
95. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
96. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
97. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
98. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
99. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
10. Figure:
Immunohistochemical
analysis of paraffin
embedded Mouse
kidney tissue. 1:
Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-j Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species MOUSE Testing Tissue KIDNEY
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
100. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
101. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
102. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
103. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
104. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
105.
106. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
107. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
108. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
109. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
110. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com
11. Figure:
Immunohistochemical
analysis of paraffin
embedded Mouse
spleen tissue. 1:
Ubiquitin Mouse
Monoclonal
Antibody(5F1) was
diluted at 1:200 (4
degree
Celsius,overnight). 2:
Sodium citrate pH 6.0
was used for antibody
retrieval (>98 degree
Celsius,20min). 3:
Secondary antibody was
diluted at 1:200 (room
temperature, 30min).
Negative control was
used by secondary
antibody only.
Report Number 97742-k Host Mouse
Application IHC-P Clonality Monoclonal
Model Number STJ97742 Clone ID 5F1
Antibody Name Anti-Ubiquitin antibody
Testing Species MOUSE Testing Tissue SPLEEN
ANTIBODY VALIDATION REPORT
b. (A small amount of distilled water was added into the incubation
box to prevent evaporation of antibody).
111. Secondary antibody incubation
a. Slides were washed 3 times, with PBS on a shaker for 5min.
Shortly after the slides were dried the corresponding secondary
antibody solution was added (HRP labelled), covering the
tissues, and incubated at room temperature for 30min.
b.
112. DAB staining
a. Slides were washed 3 times, with PBS on a shaker for 5min.
b. Shortly after, the slides were dried and fresh DAB staining buffer
was added inside the circles. The staining time was adjusted
under a microscope. Yellow-brown colour represented a positive
result. Slides were washed with water to stop the staining.
c.
113. Haematoxylin staining
a. Haematoxylin was used to counter-staining for 1min, and then
the slides were washed with water. 1% Hydrochloric acid and
alcohol was added for several seconds and then washed with
water. Ammonia was used to reveal blue colour, and then
flushed with water.
b.
114. Desolation and Clearing
i. Slides were incubated sequentially into: 75% alcohol 5min, 85%
alcohol 5min, Anhydrous ethanol - 5min, Anhydrous ethanol -
5min & Xylene - 5min. Shortly after slides were dried and neutral
gum was used to seal the slides.
ii.
115. Visualization
a. Results were validated with microscope, and the slides were
scanned.
Paraffin-Embedded
Immunohistochemistry Protocol
116.
117. Tissue processing
a. Slides were incubated sequentially into Xylene; 15min –
Xylene, 15min - Anhydrous ethanol, 5min - Anhydrous
ethanol, 5min - 85% alcohol, 5min - 75% alcohol & 5min –
wash in distilled water.
b.
118. Antigen retrieval
a. Tissue slides were incubated with citric acid (PH6.0) antigen
retrieval buffer and microwaved for antigen retrieval (heated
until boiled and then stopped heating) for 8min. Slides were
then heated with medium power for 7min. During this
process slides were kept from drying out. After cooling down
at room temperature, slides were washed with PBS on
shaker for 5min, repeated for 3 times.
b.
119. Inhibition of endogenous peroxidase
a. Slides were placed in 3% Hydrogen peroxide solution, and
incubated for 10 min at room temperature without light
exposure. Slides were then washed 3 times with PBS on a
shaker for 5mins.
b.
120. BSA Blocking
a. Shortly after slides were dried, a PAP pen was used to draw
circles around the tissue sections (and to prevent draining of
the antibody solution). Inside the circles, BSA was used to
cover the tissue evenly, blocking for 30min.
b.
121. Primary antibody incubation
After blocking solution was removed a 1:200 solution of
primary antibody/PBS was added on the slide, and incubated
overnight at 4°C.
St John's Laboratory Ltd.
www.stjohnslabs.com